These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4372511)

  • 1. Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.
    Oata M; Pak CY
    Metabolism; 1974 Dec; 23(12):1167-73. PubMed ID: 4372511
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards.
    Bone HG; Zerwekh JE; Britton F; Pak CY
    J Urol; 1979 May; 121(5):568-71. PubMed ID: 220433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY; Delea CS; Bartter FC
    N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic factors for urolithiasis in acromegalic patients.
    Heilberg IP; Czepielewski MA; Ajzen H; Ramos OL; Schor N
    Braz J Med Biol Res; 1991; 24(7):687-96. PubMed ID: 1668402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.
    Robertson WG; Peacock M; Marshall RW; Knowles F
    Clin Sci Mol Med; 1974 Jul; 47(1):13-22. PubMed ID: 4277691
    [No Abstract]   [Full Text] [Related]  

  • 7. Diminished urinary excretion of cycle AMP by rats given disodium ethane-1-hydroxy-1,1-diphosphonate.
    Goulding A; McChesney R; Malthus RS
    J Endocrinol; 1975 Apr; 65(1):145-6. PubMed ID: 167091
    [No Abstract]   [Full Text] [Related]  

  • 8. Inorganic phosphate treatment of nephrolithiasis.
    Ettinger B; Kolb FO
    Am J Med; 1973 Jul; 55(1):32-7. PubMed ID: 4715930
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of diphosphonate on calcium phosphate crystallization in urine in vitro.
    Oata M; Pak CY
    Kidney Int; 1973 Dec; 4(6):401-6. PubMed ID: 4205283
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic inhibition of diphosphonate: a proposed mechanism of tissue uptake.
    Zimmer AM; Isitman AT; Holmes RA
    J Nucl Med; 1975 May; 16(5):352-6. PubMed ID: 811772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Calcium nephrolithiasis and cellulose phosphate.
    Williams HE
    N Engl J Med; 1974 Jan; 290(4):224-5. PubMed ID: 4808920
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.
    Recker RR; Saville PD
    Toxicol Appl Pharmacol; 1973 Apr; 24(4):580-9. PubMed ID: 4197358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphosphonate therapy in nephrocalcinosis.
    McCredie DA; Powell HR; Rotenberg E
    Br J Urol; 1976 Apr; 48(2):93-100. PubMed ID: 821572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis.
    Baumann JM; Bisaz S; Fleisch H; Wacker M
    Clin Sci Mol Med; 1978 May; 54(5):509-16. PubMed ID: 108043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 19. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.